Back to search

Article

An Integrated Preclinical Platform for Lethal Neuroendocrine Prostate Cancer from Rapid Autopsy Bone and Liver Metastases

2026-07-23

Abstract excerpt

<h4>SUMMARY</h4> Treatment-emergent neuroendocrine prostate cancer (NEPC) is an aggressive, therapy-resistant disease arising in up to 20% of castration resistant prostate cancers, yet robust biologically relevant preclinical models remain scarce. Here, we describe a technical blueprint for establishing an integrated platform of patient-derived models from visceral and bone metastases collected through a prostate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ab14a583-083d-5d6d-98a2-6d2b7c6a0a04
DOI
10.64898/2026.07.22.740121
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An Integrated Preclinical Platform for Lethal Neuroendocrine Prostate Cancer from Rapid Autopsy Bone and Liver MetastasesDOI 10.64898/2026.07.22.740121
Select a neighboring publication to make it the new centre.